MTCR Insider Trading Activity and SEC Form 4 Filings
MTCR insider trading summary
No open-market insider purchases or sales of Metacrine, Inc. (MTCR) have been reported on SEC Form 4 in the past 12 months.
Latest MTCR insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 26, 2023 | Michael York | Chief Business Officer | Sell | $44K (107,054 @ $0.41) |
| Jan 26, 2023 | Preston Klassen | President & CEO | Sell | $157K (380,605 @ $0.41) |
| Dec 21, 2022 | Braden Michael Leonard | 10% Owner | Buy | $48K (120,099 @ $0.40) |
| Dec 20, 2022 | Braden Michael Leonard | 10% Owner | Buy | $19K (50,122 @ $0.38) |
| Dec 19, 2022 | Braden Michael Leonard | 10% Owner | Buy | $41K (101,384 @ $0.40) |
| Nov 9, 2022 | Braden Michael Leonard | 10% Owner | Buy | $16K (39,816 @ $0.39) |
| Nov 8, 2022 | Braden Michael Leonard | 10% Owner | Buy | $200 (500 @ $0.40) |
| Nov 7, 2022 | Braden Michael Leonard | 10% Owner | Buy | $52K (123,954 @ $0.42) |
| Oct 28, 2022 | Braden Michael Leonard | 10% Owner | Buy | $18K (45,022 @ $0.40) |
| Oct 27, 2022 | Braden Michael Leonard | 10% Owner | Buy | $299K (767,507 @ $0.39) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.